BA
The Boeing Company
BA offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
PXS
Pyxis Tankers Inc.
PXS has the edge over BA overall, supported by stronger modeled upside and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
PXS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
PXS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over PXS in the historical PE scenario, which offers more potential upside but is not a forecast.
PXS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.6x | $1.32 | -77% |
| Fair | 2.4x | $1.92 | -66% |
| Forward | 3.7x | $5.65 | — |
| Current | 7x | $5.65 | — |
| Expensive | 18x | $14.30 | +153% |
Historical ranges are pointers, not guarantees.
PXS's PE is in its expensive range at 7.0x. If earnings grow as analysts expect, today's price would be 3.7x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
PXS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for PXS, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the stronger earnings trend. Trailing diluted EPS is down 30% for BA versus PXS down 70%.
PXS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.52 | +88% |
| Q3 2024 | $2.76 | +18% |
| Q2 2024 | $2.73 | +7.1% |
| Q1 2024 | $2.54 | -6.3% |
| Q4 2023 | $3.57 | +237% |
| Q3 2023 | $2.34 | +$2.37 |
| Q2 2023 | $2.55 | +$3.42 |
| Q1 2023 | $2.71 | +$4.11 |
| Q4 2022 | $1.06 | +$2.40 |
PXS's earnings per share have fallen from their peak: $0.81 over the past year, against $3.57 in late 2023.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over PXS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
PXS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $12.1M | +33% |
| Q1 2026 | $10M | +3.9% |
| Q4 2025 | $10.5M | -12% |
| Q3 2025 | $9.7M | -30% |
| Q2 2025 | $9.2M | -34% |
| Q1 2025 | $9.6M | -19% |
| Q4 2024 | $12M | -9.2% |
| Q3 2024 | $13.8M | +24% |
PXS's revenue is recovering but still below its 2022 peak: $12M last quarter, up 33% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 36% | +46 points |
| Q1 2026 | 34% | +17 points |
| Q4 2025 | 29% | +19 points |
| Q3 2025 | 22% | -12 points |
| Q2 2025 | -9.5% | -54 points |
| Q1 2025 | 16% | -22 points |
| Q4 2024 | 11% | -35 points |
| Q3 2024 | 34% | -2.5 points |
PXS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over PXS on cash flow, with more consistent year-over-year improvement.
PXS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.8M | +88% |
| Q1 2026 | $3.4M | -17% |
| Q4 2025 | $2.3M | -62% |
| Q3 2025 | $3.3M | +78% |
| Q2 2025 | $3.1M | +$17.6M |
| Q1 2025 | $4.1M | +$23.9M |
| Q4 2024 | $6.1M | +$7.3M |
| Q3 2024 | $1.9M | +$23.4M |
PXS generated $15M in free cash flow over the past year, down 2.2% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
PXS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -98.3K shares |
| 1 year | -1.7% | -172K shares |
| 3 years | -19% | -2.4M shares |
| 5 years | +40% | +2.9M shares |
| Available history | +94% | +5M shares |
PXS has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $74,849 |
| Q1 2026 | $586,000 |
| Q4 2025 | $204,363 |
| Q3 2025 | $2,004 |
| Q2 2025 | $10,417 |
| Q1 2025 | $270,000 |
| Q4 2024 | $1.8M |
| Q3 2024 | $436,000 |
PXS spent $867,216 buying back its own shares over the past year, down 66% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
PXS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.4x | Elevated |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.5x | Moderate |
| Q3 2024 | 1.3x | Healthy |
PXS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
PXS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.9 | Neutral |
| Stochastic | 40.3 | Neutral |
PXS's weekly RSI is 49 (neutral) and its Stochastic is 40 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
PXS PE vs Industrials Sector
| Metric | PXS | Sector median | Relative |
|---|---|---|---|
| PE | 7x | 24x | 71% below |
| PE % | 72 | 58 | 14 pts above |
PXS has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
PXS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.91 | 18% below |
| 20 week MA | $5.93 | 4.7% below |
| 50 week MA | $4.68 | 21% above |
| 100 week MA | $3.89 | 45% above |
| 200 week MA | $4.20 | 35% above |
PXS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
PXS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.48 | $3.25 | -27% |
| 2021 | $3.25 | $2.15 | -34% |
| 2022 | $2.15 | $5.20 | +142% |
| 2023 | $5.20 | $4.17 | -20% |
| 2024 | $4.17 | $3.67 | -12% |
| 2025 | $3.67 | $2.95 | -20% |
| 2026 YTD | $2.95 | $5.65 | +92% |
PXS has the edge over BA on returns for 2026, with the stronger performance.